ACP
VIRX

Acuta Capital Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Acuta Capital Partners’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,429
Closed -$288K – 47
2019
Q3 		$288K Buy
+11,429
New +$288K 0.21% 29